Vice President, Business & Corporate Development @ Infinity Pharmaceuticals
Sr. VP, Strategy & Corporate Development @ Pervasis Therapeutics
BA, Economics @
Josh joined Locust Walk Partners in March 2014 after gaining extensive experience in the biotech industry. He has a successful track record in senior business development, corporate strategy and commercial roles at large and small biotech companies. Josh has closed numerous transactions across a wide array of deal structures, development stages, indications, and therapeutic modalities Prior to
Josh joined Locust Walk Partners in March 2014 after gaining extensive experience in the biotech industry. He has a successful track record in senior business development, corporate strategy and commercial roles at large and small biotech companies. Josh has closed numerous transactions across a wide array of deal structures, development stages, indications, and therapeutic modalities Prior to Locust Walk, Josh was vice president, business & corporate development at Infinity Pharmaceuticals, Inc. While at Infinity, Josh was responsible for the company’s in-licensing, out-licensing and alliance management activities.
Prior to Infinity, Hamermesh held the position of senior vice president, strategy and
corporate development at Pervasis Therapeutics, Inc., where he led strategic partnering initiatives for the company’s product development portfolio. Prior to that, he served as vice president, commercial and business development at Molecular Insight Pharmaceuticals, Inc., where he completed multiple in-licensing transactions and supported the company’s initial public offering. Hamermesh began his biotechnology career at Genzyme Corporation, where he served as chief operating officer of MG Biotherapeutics, a joint venture with Medtronic, Inc., after holding positions of increasing responsibility in marketing and business development. He also served as a business strategy consultant to the industry at the Monitor Company.
He holds an undergraduate degree, magna cum laude, from Amherst College and an M.B.A. from Harvard Business School.
Specialties: Conducting business development processes for life science companies; Structuring and negotiating business collaborations; Out-licensing biopharmaceutical products; In-licensing life science technologies; General management and strategic/ business planning for life science companies; Commercial opportunity assessments for life science technologies; Alliance management.
Vice President @ Locust Walk Partners is a life science focused, strategic and transaction advisory firm providing senior level execution support to growing life sciences companies and their investors. Our services encompass sell- and buy‐side licensing transactions and mergers and acquisitions with a clear focus on maximizing capital efficiency and financial returns. We bring a rigorous, hands‐on approach rooted in our team members’ successful track records and in‐depth operating, commercial, venture capital, and investment banking expertise. Our principals have a global network of contacts in leading life science and biopharmaceutical companies and venture capital/private equity organizations. Our firm has successfully executed several transactions and strategic planning engagements.
Our offices are located in the biotech hubs of Cambridge, Massachusetts and San Francisco, CA. From March 2014 to Present (1 year 10 months) Vice President, Business & Corporate Development @ Member of company’s executive leadership team; led out-licensing, in-licensing and alliance management activities;
Re-structured strategic alliances with Purdue/Mundipharma and Millennium/Takeda From April 2011 to February 2014 (2 years 11 months) Sr. VP, Strategy & Corporate Development @ Led partnering efforts that attracted multiple terms sheets at venture backed regenerative medicine company, which was ultimately acquired by Shire in 2012 From October 2009 to April 2011 (1 year 7 months) VP, Business & Commercial Development @ In-licensed clinical stage oncology compounds from Novartis and Bayer-Schering;
Member of company’s IPO transaction team From April 2005 to October 2008 (3 years 7 months) Sr. Director, Business Development @ Led partnering efforts for MG Biotherapeutics joint venture between Genzyme and Medtronic in the field of cardiac cell therapy From August 1999 to April 2005 (5 years 9 months) Consultant @ From September 1997 to June 1999 (1 year 10 months)
MBA, General Managment, Healthcare @ Harvard Business School From 1997 to 1999 BA, Economics @ Amherst College From 1990 to 1994 Josh Hamermesh is skilled in: Strategy, Business Development, Corporate Development, Biotechnology, Pharmaceutical Industry, Clinical Development, Oncology, Drug Development, Lifesciences, Technology Transfer, Biopharmaceuticals, Clinical Trials, Venture Capital, Drug Discovery, Start-ups
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension